Cited by 236Alzheimer's disease research and treatmentsNeurological Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Dietary salt promotes cognitive impairment through tau phosphorylation

Open access
Faraco, Giuseppe, Hochrainer, Karin, Segarra, Steven G., Schaeffer, Samantha, Santisteban, Monica M., Menon, Ajay, Jiang, Hong, Holtzman, David M. +2 more·2019·Nature

Published version of a preprint

Abstract

Dietary habits and vascular risk factors promote both Alzheimer's disease and cognitive impairment caused by vascular factors 1-3. Furthermore, accumulation of hyperphosphorylated tau, a microtubule-associated protein and a hallmark of Alzheimer's pathology 4, is also linked to vascular cognitive impairment 5,6. In mice, a salt-rich diet leads to cognitive dysfunction associated with a nitric oxide deficit in cerebral endothelial cells and cerebral hypoperfusion 7. Here we report that dietary salt induces hyperphosphorylation of tau followed by cognitive dysfunction in mice, and that these effects are prevented by restoring endothelial nitric oxide production. The nitric oxide deficiency reduces neuronal calpain nitrosylation and results in enzyme activation, which, in turn, leads to tau phosphorylation by activating cyclin-dependent kinase 5. Salt-induced cognitive impairment is not observed in tau-null mice or in mice treated with anti-tau antibodies, despite persistent cerebral hypoperfusion and neurovascular dysfunction. These findings identify a causal link between dietary salt, endothelial dysfunction and tau pathology, independent of haemodynamic insufficiency. Avoidance of excessive salt intake and maintenance of vascular health may help to stave off the vascular and neurodegenerative pathologies that underlie dementia in the elderly.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-019-1688-z

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a vascular injury model induced by high-salt diet, tau ablation rescued molecular pathways underlying neurovascular dysfunction.

    “In a vascular injury model induced by high-salt diet, tau ablation rescued molecular pathways underlying neurovascular dysfunction [87].”

    From Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease (2026) · cites this paper as [87]

    The tau-null experiment (passage [6]) reports that high-salt-fed mice avoided cognitive impairment but still had an attenuated cerebral blood-flow response, a measure of neurovascular dysfunction. The Abstract (passage [2]) likewise says cognitive impairment was absent despite persistent hypoperfusion and neurovascular dysfunction. Tau ablation therefore rescued cognition, not the neurovascular dysfunction attributed to it in the claim. (LLM, conf=0.92)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Tau ablation improves outcomes in models of TBI and high-salt diet-induced vascular dysfunction, with improvements in cognitive performance.

    “Beyond neurodegenerative and neurodevelopmental disorders, tau ablation has also been shown to improve outcomes in models of neurological injury and vascular stress, such TBI and high-salt diet-induced vascular dysfunction, with associated improvements in cognitive performance [72, 86, 87].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 38

  1. [2]van de Rest O, Berendsen AA, Haveman-Nies A & de Groot LC Dietary patterns, cognitive decline, and dementia: a systematic review. Adv Nutr 6, 154– 168, 10.3945/an.114.007617 (2015). 25770254 PMC4352174 · DOI
  2. [3]Kendig MD & Morris MJ Reviewing the effects of dietary salt on cognition: mechanisms and future directions. Asia Pac J Clin Nutr 28, 6– 14, 10.6133/apjcn.201903_28(1).0002 (2019). 30896408 · DOI
  3. [5]Nation DA Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults. JAMA Neurol 72, 546– 553, 10.1001/jamaneurol.2014.4477 (2015). 25822631 PMC4428938 · DOI
  4. [6]Kim HJ Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging. JAMA Neurol 75, 999– 1007, 10.1001/jamaneurol.2018.0975 (2018). 29799981 PMC6142932 · DOI
  5. [9]Gardener H, Rundek T, Wright CB, Elkind MS & Sacco RL Dietary sodium and risk of stroke in the Northern Manhattan study. Stroke 43, 1200– 1205, 10.1161/STROKEAHA.111.641043 (2012). 22499576 PMC3347890 · DOI · Paper page
  6. [10]Blumenthal JA Lifestyle and neurocognition in older adults with cognitive impairments: A randomized trial. Neurology 92, e212– e223, 10.1212/WNL.0000000000006784 (2019). 30568005 PMC6340382 · DOI
  7. [11]Heye AK Blood pressure and sodium: Association with MRI markers in cerebral small vessel disease. J Cereb Blood Flow Metab 36, 264– 274, 10.1038/jcbfm.2015.64 (2016). 25899292 PMC4758556 · DOI
  8. [13]Sweeney MD Vascular dysfunction-The disregarded partner of Alzheimer’s disease. Alzheimers Dement 15, 158– 167, 10.1016/j.jalz.2018.07.222 (2019). 30642436 PMC6338083 · DOI · Paper page
  9. [14]Shi Y Cerebral blood flow in small vessel disease: A systematic review and meta-analysis. J Cereb Blood Flow Metab 36, 1653– 1667, 10.1177/0271678X16662891 (2016). 27496552 PMC5076792 · DOI
  10. [15]Marshall RS Recovery of brain function during induced cerebral hypoperfusion. Brain 124, 1208– 1217 (2001). 11353736
  11. [16]Wang Y & Mandelkow E Tau in physiology and pathology. Nat Rev Neurosci 17, 5– 21, 10.1038/nrn.2015.1 (2016). 26631930 · DOI · Paper page
  12. [17]Zhao Y Sodium Intake Regulates Glucose Homeostasis through the PPARdelta/Adiponectin-Mediated SGLT2 Pathway. Cell Metab 23, 699– 711, 10.1016/j.cmet.2016.02.019 (2016). 27053360 · DOI
  13. [19]Iadecola C SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci 2, 157– 161, 10.1038/5715 (1999). 10195200 · DOI · Paper page
  14. [21]Arendt T, Stieler JT & Holzer M Tau and tauopathies. Brain Res Bull 126, 238– 292, 10.1016/j.brainresbull.2016.08.018 (2016). 27615390 · DOI · Paper page
  15. [22]Lee MS Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360– 364, 10.1038/35012636 (2000). 10830966 · DOI
  16. [23]Patrick GN Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615– 622, 10.1038/45159 (1999). 10604467 · DOI
  17. [24]Austin SA & Katusic ZS Loss of Endothelial Nitric Oxide Synthase Promotes p25 Generation and Tau Phosphorylation in a Murine Model of Alzheimer’s Disease. Circ Res 119, 1128– 1134, 10.1161/CIRCRESAHA.116.309686 (2016). 27601478 PMC5085902 · DOI
  18. [25]Bibb JA Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 402, 669– 671, 10.1038/45251 (1999). 10604473 · DOI
  19. [26]Shukla V A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer’s disease phenotypes in model mice. FASEB J 27, 174– 186, 10.1096/fj.12-217497 (2013). 23038754 PMC3528323 · DOI
  20. [27]Kimura T Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclin-dependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites. J Biol Chem 288, 7968– 7977, 10.1074/jbc.M112.433326 (2013). 23362255 PMC3597833 · DOI
  21. [28]Ono Y, Saido TC & Sorimachi H Calpain research for drug discovery: challenges and potential. Nat Rev Drug Discov 15, 854– 876, 10.1038/nrd.2016.212 (2016). 27833121 · DOI
  22. [29]Etwebi Z, Landesberg G, Preston K, Eguchi S & Scalia R Mechanistic Role of the Calcium-Dependent Protease Calpain in the Endothelial Dysfunction Induced by MPO (Myeloperoxidase). Hypertension 71, 761– 770, 10.1161/HYPERTENSIONAHA.117.10305 (2018). 29507101 PMC6467284 · DOI
  23. [30]Qu J S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide. Proc Natl Acad Sci U S A 108, 14330– 14335, 10.1073/pnas.1105172108 (2011). 21844361 PMC3161554 · DOI
  24. [31]Iadecola C The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease. Neuron 96, 17– 42, 10.1016/j.neuron.2017.07.030 (2017). 28957666 PMC5657612 · DOI · Paper page
  25. [32]Yanamandra K Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron 80, 402– 414, 10.1016/j.neuron.2013.07.046 (2013). 24075978 PMC3924573 · DOI · Paper page
  26. [33]Powles J Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open 3, e003733, 10.1136/bmjopen-2013-003733 (2013). PMC3884590 24366578 · DOI · Paper page
  27. [34]Hochrainer K The ubiquitin ligase HERC3 attenuates NF-kappaB-dependent transcription independently of its enzymatic activity by delivering the RelA subunit for degradation. Nucleic Acids Res 43, 9889– 9904, 10.1093/nar/gkv1064 (2015). 26476452 PMC4787756 · DOI
  28. [35]Shukla V TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice. J Alzheimers Dis 56, 335– 349, 10.3233/JAD-160916 (2017). 28085018 PMC10020940 · DOI
  29. [36]Faraco G Circulating endothelin-1 alters critical mechanisms regulating cerebral microcirculation. Hypertension 62, 759– 766, 10.1161/HYPERTENSIONAHA.113.01761 (2013). 23959559 PMC3874144 · DOI
  30. [37]Kober F High-resolution myocardial perfusion mapping in small animals in vivo by spin-labeling gradient-echo imaging. Magn Reson Med 51, 62– 67, 10.1002/mrm.10676 (2004). 14705046 · DOI
  31. [38]Petry FR Specificity of anti-tau antibodies when analyzing mice models of Alzheimer’s disease: problems and solutions. PLoS One 9, e94251, 10.1371/journal.pone.0094251 (2014). 24788298 PMC4008431 · DOI
  32. [39]Faraco G Hypertension enhances Abeta-induced neurovascular dysfunction, promotes beta-secretase activity, and leads to amyloidogenic processing of APP. J Cereb Blood Flow Metab 36, 241– 252, 10.1038/jcbfm.2015.79 (2016). 25920959 PMC4758560 · DOI · Paper page
  33. [40]Voit A Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice. Nat Commun 8, 1068, 10.1038/s41467-017-01146-7 (2017). 29051551 PMC5648780 · DOI
  34. [41]Liu W Metabolic stress-induced cardiomyopathy is caused by mitochondrial dysfunction due to attenuated Erk5 signaling. Nat Commun 8, 494, 10.1038/s41467-017-00664-8 (2017). 28887535 PMC5591279 · DOI
  35. [42]Forrester MT, Foster MW, Benhar M & Stamler JS Detection of protein S-nitrosylation with the biotin-switch technique. Free Radic Biol Med 46, 119– 126, 10.1016/j.freeradbiomed.2008.09.034 (2009). 18977293 PMC3120222 · DOI
  36. [43]Cohen SJ & Stackman RW Jr. Assessing rodent hippocampal involvement in the novel object recognition task. A review. Behav Brain Res 285, 105– 117, 10.1016/j.bbr.2014.08.002 (2015). 25169255 PMC7008635 · DOI
  37. [44]Grayson B Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents. Behav Brain Res 285, 176– 193, 10.1016/j.bbr.2014.10.025 (2015). 25447293 · DOI
  38. [45]O’Leary TP & Brown RE Optimization of apparatus design and behavioral measures for the assessment of visuo-spatial learning and memory of mice on the Barnes maze. Learn Mem 20, 85– 96, 10.1101/lm.028076.112 (2013). 23322557 · DOI

Cited by

Sorted by citations

Authors
Faraco, G., Hochrainer, K., Segarra, S. G., Schaeffer, S., Santisteban, M. M., Menon, A., Jiang, H., Holtzman, D. M., Anrather, J., & Iadecola, C.
Affiliations
  • Weill Cornell Medicine (US)
  • Washington University in St. Louis (US)
Corresponding author
  • Faraco, Giuseppe
  • Iadecola, Costantino
Venue
Nature
Published
2019-10-23
Volume
574
Issue
7780
Pages
686-690
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2981842151
Cited by
236
References
10
Citations by year
2026: 29 · 2025: 41 · 2024: 35 · 2023: 29 · 2022: 42 · 2021: 33 · 2020: 23 · 2019: 4
FWCI
17.49
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • American Heart Association
  • Cure Alzheimer's Fund
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (R01NS109588, R37NS089323, R01NS095441)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
dietary salt, hyperphosphorylated tau, cognitive impairment, vascular cognitive impairment, Alzheimer's disease, endothelial nitric oxide, cyclin-dependent kinase 5, cerebral hypoperfusion, neurovascular dysfunction, endothelial dysfunction
MeSH terms
Alzheimer Disease, Animals, Brain, Humans, Neurons, Phosphorylation, tau Proteins, Sodium Chloride, Dietary, Mice, Knockout, Mice, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review